19 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Chung, Rheumatologist in Stanford, CA?
Castle Connolly Top Doctor
Castle Connolly Top Doctors are doctor-nominated and selected by a physician-led research team.
What are Areas of Expertise for Dr. Chung?
Dr. Lorinda Chung, MD is a highly-rated, board-certified Rheumatologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Chung empowers patients to confidently navigate their health journey, specializing in Connective Tissue Disorders, Dermatomyositis, Scleroderma, and comprehensive wellness support. Serving the Stanford, CA community, Dr. Chung is dedicated to enhancing lives through expert, patient-centered care.
What languages does Dr. Chung speak?
Dr. Chung and their clinical team can communicate with patients in the following languages:
- English
What conditions does a Rheumatologist like Dr. Chung typically treat?
As a Rheumatologist, Dr. Chung diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Chung. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Scleroderma
- Systemic scleroderma
- Systemic Sclerosis
- Hardening of the Skin
- Connective Tissue Disease
ICD-10 Codes:
- M349: Systemic sclerosis, unspecified
Also known as:
- Myositis
- Dermatomyositis
- Polymyositis
- Muscle Inflammation
ICD-10 Codes:
- M3390: Dermatopolymyositis, unspecified, organ involvement unspecified
Also known as:
- Dermatomyositis without muscle weakness
- Dermatomyositis sine myositis
- DM without muscle involvement
- Adult skin inflammation without muscle pain
ICD-10 Codes:
- M3313: Other dermatomyositis without myopathy
Also known as:
- Raynaud's Phenomenon
- Raynaud Phenomenon
- Raynaud’s Phenomenon
- Raynaud's Disease
- Raynaud's Syndrome
- Cold Fingers and Toes
ICD-10 Codes:
- I7300: Raynaud's syndrome without gangrene
Also known as:
- Joint Pain
- Joint Disorder
- Pain
- Arthralgia
- Aching joints
- Sore joints
ICD-10 Codes:
- M2550: Pain in unspecified joint
Also known as:
- Connective Tissue Disorder
- Systemic Connective Tissue Disease
- Rheumatic Connective Tissue Disease
- Autoimmune Connective Tissue Disease
ICD-10 Codes:
- M359: Systemic involvement of connective tissue, unspecified
Also known as:
- Shortness of Breath
- Breathing Problems
- Difficulty breathing
- Breathlessness
- Dyspnea
ICD-10 Codes:
- R0602: Shortness of breath
What procedures does a Rheumatologist like Dr. Chung typically perform?
As a Rheumatologist, procedures performed by Dr. Lorinda Chung may include:
- Abnormal ANA Testing
- Arthrocentesis
- Denosumab Injection
- Joint Aspiration
- Joint Injections
- Rheumatology Consultation
- Rheumatology Follow Up
- Viscosupplement Injections
Please contact Dr. Chung's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Chung accept my insurance?
Dr. Chung accepts most major insurance plans. Important: Please call our office at (650) 493-5000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Chung accept in Stanford, CA?
Dr. Chung in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Blue Shield of California
Cigna Group
CVS Health (formerly Aetna)
Kaiser Permanente
Medicaid
Medicare
Santa Cruz County
State of California
UMR Administered Payer
UnitedHealth Group
View All Insurances
Where is Dr. Chung's office located?
What hospitals are Dr. Chung affiliated with?
Castle Connolly Top Hospital
This doctor is affiliated with a Castle Connolly Top Hospital.
Dr. Chung has admitting privileges at the following hospitals:
Recognitions
Publications
Multicriteria decision alysis methods with 1000Minds for developing systemic sclerosis cl, 2014
Survival and Predictors of Mortality in Systemic Sclerosis-Associated Pulmory Arterial Hypertension, 2014
Atherosclerotic Cardiovascular Disease in Hospitalized Patients With Systemic Sclerosis, 2014
Intertiol consensus criteria for the diagnosis of Rayud's phenomenon., 2014
Consensus opinion of a North American Working Group regarding the cl, 2014
Recommendations for Screening, 2013
Most Patients With Cancer-Associated Dermatomyositis Have Antibodies to Nuclear Matrix Protein NXP, 2013
2013 classification criteria for systemic sclerosis: an American college of rheumatology, 2013
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology, 2013
Functiol Class Improvement, 2013
Magement of the hand in systemic sclerosis., 2013
Localized cutaneous fibrosing disorders., 2013
Dyspnea Assessment and Pulmory Hypertension in Patients With Systemic Sclerosis, 2013
Epidemiology and risk factors for pulmory hypertension in systemic sclerosis., 2013
Atherosclerotic cardiovascular disease and dermatomyositis, 2013
Clinical presentation and evaluation of dermatomyositis., 2012
Hyperuricemia in Young Adults and Risk of Insulin Resistance, Prediabetes, 2012
Items for developing revised classification criteria in systemic sclerosis, 2012
Clinical trial design in scleroderma: where are we and where do we go next?, 2012
Tyrosine kises in inflammatory dermatologic disease, 2011
The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5, 2011
Pathogenesis of dermatomyositis: role of cytokines and interferon., 2011
An Alysis of Connective Tissue Disease, 2011
Colonic ulceration as an unusual manifestation of vasculopathy in systemic sclerosis, 2011
Endothelin Receptor Antagonists for the Treatment of Rayud's Phenomenon, 2011
Hyperuricemia and the risk for subclinical corory atherosclerosis, 2011
Characterization of Connective Tissue Disease, 2010
A 39-Year-Old Woman With Lupus, Myositis, and a Recalcitrant Vasculopathy, 2010
Digital ischemic loss in systemic sclerosis., 2010
Vascular disease in systemic sclerosis., 2010
Characterizing systemic sclerosis in Northern California: focus on Asian and Hispanic patients, 2009
Characterizing systemic sclerosis in Northern California: focus on Asian and Hispanic patients., 2009
MQX-503, a Novel Formulation of Nitroglycerin, 2009
Molecular Framework for Response to Imatinib Mesylate in Systemic Sclerosis, 2009
Maligncy in the Setting of the Anti-Synthetase Syndrome, 2008
Pregncy outcomes in systemic sclerosis, primary pulmory hypertension, and sickle cell disease, 2008
Hospitalizations and mortality in systemic sclerosis: results from the tionwide Inpatient Sample, 2007
A pilot trial of rituximab in the treatment of patients with dermatomyositis, 2007
Therapeutic options for digital ulcers in patients with systemic sclerosis., 2007
A pilot study of tumor necrosis factor inhibition in erosive, 2007
Successful use of rituximab for cutaneous vasculitis, 2006
Systemic and locatized scleroderma, 2006
A pilot trial of treprostinil for the treatment, 2006
Digital ulcers in patients with systemic sclerosis, 2006
Outcome of pregncies complicated by systemic sclerosis and mixed connective tissue disease, 2006
Bleeding complications in patients on celecoxib and warfarin, 2005
Giant cell myocarditis, 2005
Antibodies in scleroderma: direct pathogenicity and phenotypic associations., 2004
What is Dr. Chung's NPI number?A National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Chung's National Provider Identifier (NPI) number is 1427026442.
What common questions do patients ask about Dr. Chung?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Chung